ZENNER PATRICK J - 31 Mar 2022 Form 4 Insider Report for WEST PHARMACEUTICAL SERVICES INC (WST)

Reporting relationship: Director
Issuer ticker: WST
Reported as of: 31 Mar 2022
Net transaction value: +$20,125
SEC form: 4
Accepted by SEC: 01 Apr 2022, 16:05:31 UTC
Prior SEC filing: 05 Jan 2022
Next SEC filing: 04 Jan 2023
Source filing: View source filing
Reporting owner signature: Ryan Metz as Agent for Patrick J. Zenner

Key filing fact

ZENNER PATRICK J filed Form 4 for WEST PHARMACEUTICAL SERVICES INC (WST) on 01 Apr 2022.

Key facts

This page summarizes ZENNER PATRICK J's Form 4 filing for WEST PHARMACEUTICAL SERVICES INC (WST).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Apr 2022, 16:05.

Change

Previous filing in this sequence was filed on 05 Jan 2022.
Current net transaction value: +$20,125.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WST holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 39,974
Date: 31 Mar 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WST transaction Derivative

Phantom Stock Unit

Award

Transaction value: $20,125
Shares: +49
Change %: +0.45%
Price: $410.71
Shares after: 10,928
Date: 31 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 49
Exercise price
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .